Plain-English translation of NCT07308990 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether removing more lymph nodes during prostate cancer surgery leads to better results than removing fewer lymph nodes. Men with prostate cancer who need surgery will be randomly assigned to receive either limited lymph node removal or extended lymph node removal as part of their operation. The study will follow patients to see which approach works better.
Doctors are not sure exactly how many lymph nodes should be removed during prostate cancer surgery to get the best outcomes. This trial will help determine whether removing more lymph nodes reduces cancer recurrence and improves survival, or whether the same results can be achieved with less extensive removal.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to one of two groups: one group will receive prostate removal surgery with limited lymph node dissection, and the other will receive the same surgery with more extensive lymph node removal. After surgery, your medical team will monitor your recovery and follow your progress over time to compare outcomes between the two groups. The study will track your health status and any signs of cancer recurrence.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Belarus